Stathmin Immunoreactivity in Phaeochromocytomas and Paragangliomas: Differential Expression Between Benign and Malignant Neoplasms
This study aimed to assess stathmin expression in benign and malignant phaeochromocytomas and paragangliomas. Methods: Tissue specimens from 37 patients with malignant phaeochromocytomas (n = 5), malignant paragangliomas (n = 3), benign phaeochromocytomas (n = 24), and benign paragangliomas (n = 5)...
Main Authors: | Wei-Chou Lin, Shyh-Chyan Chen, Yuan-Ting Chuang, Kuan-Lin Kuo, Kuo-How Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958411600134 |
Similar Items
-
The clinical genetics of phaeochromocytoma and paraganglioma
by: P. T. Kavinga Gunawardane, et al. -
Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
by: A Al-Sharefi, et al.
Published: (2018-10-01) -
Glucose Intolerance on Phaeochromocytoma and Paraganglioma—The Current Understanding and Clinical Perspectives
by: Ichiro Abe, et al.
Published: (2020-11-01) -
Phaeochromocytoma in a 20-year-old Nigerian, resolving the dilemma of benignity or malignancy
by: Fred O. Ugwumba, et al.
Published: (2012-01-01) -
A malignant phaeochromocytoma, the largest reported from Asia: a case report
by: W. A. N. T. Wickramarachchi, et al.
Published: (2020-06-01)